• 2014.09.30

    New collaboration in the development of advanced therapies
  • 2014.09.30

    Sumitomo Dainippon Pharma Acquires Patent License from DNAVEC On Clinical-grade iPS Cell Production Technology
  • 2014.09.29

    ReproCELL Launches the Operation of Cell Innovation Partners, L.P., Corporate Venture Capital Fund, with Shinsei Bank, Limited
  • 2014.09.25

    Kyoto University has appointed Mr. Shinji Asonuma, a Program-Specific Researcher of the Center for iPS Cell Research and Application (CiRA), as the next Director-General of the Office of Society-Academia Collaboration for Innovation.
  • 2014.09.18

    Researchers use iPS cells to show statin effects on diseased bone
  • 2014.09.16

    Cell reprogramming recapitulates type II collagenopathy in cells and mice
  • 2014.09.12

    Resetting human conventional pluripotent stem cells to the earliest human stem cells
  • 2014.09.12

    First RPE cell sheet graft transplant
  • 2014.09.10

    Transient vascularization of transplanted human adult–derived progenitors promotes self-organizing cartilage
  • 2014.09.08

    ReproCELL Acquires the iPS Cell Business Unit of Stemgent, Inc.


See more

Page top



  • MEXT
  • Japan Science and Technology Agency
Page top